Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany

References

• Wolfe F. The epidemiology of fibromyalgia. J Musculoskeletal Pain 1993;1:137–481Wolfe F. The epidemiology of fibromyalgia. J Musculoskeletal Pain 1993;1:137–48
   Google Scholar
• Campbell SM, Clark S, Tindall EA. et al. Clinical characteristics of fibrositis. I. A ‘blinded’, controlled study of symptoms and tender points. Arthritis Rheum 1983;26:817–242Campbell SM, Clark S, Tindall EA. et al. Clinical characteristics of fibrositis. I. A ‘blinded’, controlled study of symptoms and tender points. Arthritis Rheum 1983;26:817–24
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160–723Wolfe F, Smythe HA, Yunus MB. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160–72
   PubMed Web of Science ®Google Scholar
• Goldenberg DL. Office management of fibromyalgia. Rheum Dis Clin North Am 2002;28:437–464Goldenberg DL. Office management of fibromyalgia. Rheum Dis Clin North Am 2002;28:437–46
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ. et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52:1264–735Crofford LJ, Rowbotham MC, Mease PJ. et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52:1264–73
   PubMed Web of Science ®Google Scholar
• Arnold LM, Rosen A, Pritchett YL. et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5–156Arnold LM, Rosen A, Pritchett YL. et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5–15
   PubMed Web of Science ®Google Scholar
• Arnold LM, Lu Y, Crofford LJ. et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974–847Arnold LM, Lu Y, Crofford LJ. et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974–84
   PubMed Web of Science ®Google Scholar
• Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 2004; 51:9–138Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 2004; 51:9–13
   PubMed Web of Science ®Google Scholar
• Arnold LM, Hess EV, Hudson JI. et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002;112: 191–79Arnold LM, Hess EV, Hudson JI. et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002;112: 191–7
   PubMed Web of Science ®Google Scholar
• Goldenberg D, Mayskiy M, Mossey C. et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39: 1852–910Goldenberg D, Mayskiy M, Mossey C. et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39: 1852–9
   PubMed Web of Science ®Google Scholar
• Carette S, Bell MJ, Reynolds WJ. et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum 1994;37:32–4011Carette S, Bell MJ, Reynolds WJ. et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum 1994;37:32–40
   PubMed Web of Science ®Google Scholar
• Santandrea S, Montrone F, Sarzi-Puttini P. et al. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 1993;21:74–8012Santandrea S, Montrone F, Sarzi-Puttini P. et al. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 1993;21:74–80
   PubMed Web of Science ®Google Scholar
• Russell IJ, Fletcher EM, Michalek JE. et al. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum 1991;34:552–6013Russell IJ, Fletcher EM, Michalek JE. et al. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum 1991;34:552–60
   PubMed Web of Science ®Google Scholar
• Gendreau RM, Thorn MD, Gendreau JF. et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32: 1975–8514Gendreau RM, Thorn MD, Gendreau JF. et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32: 1975–85
   PubMed Web of Science ®Google Scholar
• Goldenberg DL. Fibromyalgia: treatment problems. J Musculoskeletal Pain 1993;1:71–8115Goldenberg DL. Fibromyalgia: treatment problems. J Musculoskeletal Pain 1993;1:71–81
   Google Scholar
• Lyrica (prescribing information). http://www.pfizer.com/files/products/uspi_lyrica.pdf [Accessed 16/1/2007].16Lyrica (prescribing information). http://www.pfizer.com/files/products/uspi_lyrica.pdf [Accessed 16/1/2007].
   Google Scholar
• Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia – a different type of pain needing a different type of treatment. Nat Clin Pract Rheum 2006;2:364–7217Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia – a different type of pain needing a different type of treatment. Nat Clin Pract Rheum 2006;2:364–72
   PubMedGoogle Scholar
• Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 2005;9:399–40418Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 2005;9:399–404
   PubMedGoogle Scholar
• Rao SG, Clauw DJ. The management of fibromyalgia. Drugs Today 2004;40:539–5419Rao SG, Clauw DJ. The management of fibromyalgia. Drugs Today 2004;40:539–54
   PubMed Web of Science ®Google Scholar
• Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 1996;34:924–3020Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 1996;34:924–30
   PubMed Web of Science ®Google Scholar
• White KP, Speechley M, Harth M. et al. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999;26:1577–8521White KP, Speechley M, Harth M. et al. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999;26:1577–85
   PubMed Web of Science ®Google Scholar
• Wolfe F, Anderson J, Harkness D. et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997;40:1560–7022Wolfe F, Anderson J, Harkness D. et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997;40:1560–70
   PubMed Web of Science ®Google Scholar
• Penrod JR, Bernatsky S, Adam V. et al. Health services costs and their determinants in women with fibromyalgia. J Rheumatol 2004;31:1391–823Penrod JR, Bernatsky S, Adam V. et al. Health services costs and their determinants in women with fibromyalgia. J Rheumatol 2004;31:1391–8
   PubMed Web of Science ®Google Scholar
• Robinson RL, Birnbaum HG, Morley MA. et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003;30:1318–2524Robinson RL, Birnbaum HG, Morley MA. et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003;30:1318–25
   PubMed Web of Science ®Google Scholar
• Hughes G, Martinez C, Myon E. et al. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006;54:177–8325Hughes G, Martinez C, Myon E. et al. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006;54:177–83
   PubMed Web of Science ®Google Scholar
• Boonen A, van den Heuvel R, van Tubergen A. et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylosis. Ann Rheum Dis 2005;64:396–40226Boonen A, van den Heuvel R, van Tubergen A. et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylosis. Ann Rheum Dis 2005;64:396–402
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes E, Martin S. et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007;61:1498–50827Berger A, Dukes E, Martin S. et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007;61:1498–508
   PubMed Web of Science ®Google Scholar
• Dietlein G, Schroder-Bernhardi D. Use of the Mediplus patient database in healthcare research. Int J Clin Pharm Ther 2002; 40:130–328Dietlein G, Schroder-Bernhardi D. Use of the Mediplus patient database in healthcare research. Int J Clin Pharm Ther 2002; 40:130–3
   PubMed Web of Science ®Google Scholar
• World Health Organization. International statistical classification of diseases and related health problems, 10th revision: version for 2007. http://www.who.int/classifications/apps/icd/icd10online/ [Accessed 23/6/2008].29World Health Organization. International statistical classification of diseases and related health problems, 10th revision: version for 2007. http://www.who.int/classifications/apps/icd/icd10online/ [Accessed 23/6/2008].
   Google Scholar
• World Health Organization. Cancer pain relief. Geneva, Switzerland: World Health Organization; 1996.30World Health Organization. Cancer pain relief. Geneva, Switzerland: World Health Organization; 1996.
   Google Scholar
• Brant JM. Cancer-related neuropathic pain. Nurse Pract Forum 1998;9:154–6231Brant JM. Cancer-related neuropathic pain. Nurse Pract Forum 1998;9:154–62
   PubMedGoogle Scholar
• Kanner R. Diagnosis and management of neuropathic pain in patients with cancer. Cancer Invest 2001;19:324–3332Kanner R. Diagnosis and management of neuropathic pain in patients with cancer. Cancer Invest 2001;19:324–33
   PubMed Web of Science ®Google Scholar
• George RM, Ahmedzai SH. The management of neuropathic pain in cancer: clinical guidelines for the use of adjuvant analgesics. Indian J Cancer 2000;37:4–933George RM, Ahmedzai SH. The management of neuropathic pain in cancer: clinical guidelines for the use of adjuvant analgesics. Indian J Cancer 2000;37:4–9
   PubMedGoogle Scholar
• Allen RR. Neuropathic pain in the cancer patient. Neuropathic Pain Syndromes 1998;16:869–8734Allen RR. Neuropathic pain in the cancer patient. Neuropathic Pain Syndromes 1998;16:869–87
   Google Scholar
• Katz N. Neuropathic pain in cancer and AIDS. Clin J Pain 2000;16:S41–S4835Katz N. Neuropathic pain in cancer and AIDS. Clin J Pain 2000;16:S41–S48
   PubMed Web of Science ®Google Scholar
• Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988;33:11–2336Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988;33:11–23
   PubMed Web of Science ®Google Scholar
• Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987;147:1442–437Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987;147:1442–4
   PubMed Web of Science ®Google Scholar
• Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium. Drugs 2001;61:955–7738Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium. Drugs 2001;61:955–77
   PubMed Web of Science ®Google Scholar
• Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology 2001;15:1435–4539Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology 2001;15:1435–45
   PubMed Web of Science ®Google Scholar
• Oster G, Berger A, Dukes E. et al. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother 2004;2:163–7040Oster G, Berger A, Dukes E. et al. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother 2004;2:163–70
   PubMedGoogle Scholar
• Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143–941Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143–9
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes E, Mercadante S. et al. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care 2006;15:138–4542Berger A, Dukes E, Mercadante S. et al. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care 2006;15:138–45
   PubMed Web of Science ®Google Scholar
• SAS proprietary software, release 8.4, SAS Institute Inc., Cary, NC.43SAS proprietary software, release 8.4, SAS Institute Inc., Cary, NC.
   Google Scholar
• Oliver K, Cronan TA, Walen HR. et al. Effects of social support and education on health care costs for patients with fibromyalgia. J Rheumatol 2001;28:2711–944Oliver K, Cronan TA, Walen HR. et al. Effects of social support and education on health care costs for patients with fibromyalgia. J Rheumatol 2001;28:2711–9
   PubMed Web of Science ®Google Scholar